(Q47794474)

English

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

Susanne Krüger Kjaer

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

author name string

Estrid V S Høgdall

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Lise Christensen

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Jan Blaakaer

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Johannes E Bock

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Eva Glud

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Bent Nørgaard-Pedersen

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

Claus K Høgdall

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

98

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

66-73

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

The role of the HER-2/neu oncogene in gynecologic cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

The CA 125 tumour-associated antigen: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

Fibrin degradation products and ovarian tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

The fibrinolytic system. A key to tumor metastasis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

Pathways of coagulation/fibrinolysis activation in malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

The genetic analysis of ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

21 January 2018

How cancer arises.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma tetranectin and ovarian neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma tetranectin is reduced in cancer and related to metastasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erbB-2 oncogene expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11476

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11476

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12833457

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47794474&oldid=2171159633"